A folate receptor–targeted NIR-II probe improves intraoperative imaging and surgery of metastatic ovarian cancer
Science Advances · 02.10.2026 · 12 (40)
DOI: 10.1126/sciadv.aed7722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 02.10.2026. Verfasst von Wanying Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, P. R. China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Folate Receptor 1, Optical Imaging, Fluorescent Dyes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Intraoperative fluorescence imaging holds great promise for achieving complete cytoreduction in ovarian cancer, but its clinical utility is currently constrained by the limitations of existing imaging agents. In particular, the leading clinical probe, OTL38, operates in the near-infrared I (NIR-I; 700 to 1000 nanometers) window, which suffers from limited tissue penetration and suboptimal resolution. Here, a folate receptor α (FRα)–targeted NIR-II (1000 to 3000 nanometers) imaging probe was developed by incorporating a 4-(4-iodophenyl)butanoic acid moiety. This structural modification enables albumin binding, thereby prolonging systemic circulation and enhancing accumulation in FRα-positive tumors. In murine models of peritoneal metastasis, our probe enabled precise visualization of occult lesions undetectable by the naked eye. Compared to OTL38, this probe demonstrated superior tumor detection sensitivity (90.20% versus 78.75%) and allowed for the reliable identification of elusive lesions less than or equal to 3 millimeters in diameter. These findings highlight the potential of albumin-binding NIR-II imaging strategies to overcome the limitations of current clinical probes and enhance precision fluorescence–guided surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, P. R. China.
- Laboratory of Female Reproductive Health, The First Hospital of Jilin University, Changchun 130021, P. R. China.
- Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, The First Hospital of Jilin University, Changchun 130021, P. R. China.
- State Key Laboratory of Supramolecular Structure and Materials, Center for Supramolecular Chemical Biology, College of Chemistry, Jilin University, Changchun 130012, P.R. China.
- Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun 130021, P. R. China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117544, Singapore.
ORCID-Profile: Wanying Li, Zimu Yuan, Yuewei Zhang, Tianyang Han, Yuhuan Li, Xiaosen Li, Shoujun Zhu, Qi Zhou, Songling Zhang, Xin Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Yuan, Z., Bai, S., Zhang, Y., Han, T., Li, Y., Li, X., Zhu, S., Zhou, Q., Zhang, S., & Wang, X. (2026). A folate receptor–targeted NIR-II probe improves intraoperative imaging and surgery of metastatic ovarian cancer. Science Advances, 12(40). https://doi.org/10.1126/sciadv.aed7722
Vancouver
Li W, Yuan Z, Bai S, Zhang Y, Han T, Li Y, et al. A folate receptor–targeted NIR-II probe improves intraoperative imaging and surgery of metastatic ovarian cancer. Science Advances. 2026;12(40). doi:10.1126/sciadv.aed7722
BibTeX
@article{Li2026,
author = {Li, Wanying and Yuan, Zimu and Bai, Shiqi and Zhang, Yuewei and Han, Tianyang and Li, Yuhuan and Li, Xiaosen and Zhu, Shoujun and Zhou, Qi and Zhang, Songling and Wang, Xin},
title = {A folate receptor–targeted NIR-II probe improves intraoperative imaging and surgery of metastatic ovarian cancer},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {40},
doi = {10.1126/sciadv.aed7722}
}
EUVIMED